Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest congenital heart disease Stories

2012-10-01 23:01:51

More than 152 Zoloft Lawsuits Pending in U.S District Court, Eastern District of Pennsylvania, Allege Zoloft Caused Birth Defects when Ingested by Pregnant Women. Melville, NY (PRWEB) October 01, 2012 The Zoloft birth defect lawyers at Alonso Krangle LLP, a leading national law firm focused on fighting for the rights of serious personal injury victims, report that the federal litigation recently established for Zoloft birth defect lawsuits is moving forward, with the litigation´s next...

2012-09-14 02:24:07

James Hammel, M.D., shares expertise with surgeons from U.S., Europe OMAHA, Neb., Sept. 14, 2012 /PRNewswire-USNewswire/ -- Congenital heart surgeon James Hammel, M.D., on Thursday presented a video demonstration of a novel infant cardiac surgical technique at the joint meeting of the Congenital Heart Surgeons' Society and the European Congenital Heart Surgeons Association in Chicago. The technique allows many complex heart defect repairs, including the Norwood operation for hypoplastic...

2012-07-11 14:20:44

PITTSBURGH, July 11, 2012 /PRNewswire/ -- Rock for the Heart Foundation presents Heart Strings - featuring the North American premiere of Sir Paul McCartney's, NOVA, an orchestral adaptation composed by McCartney for his late wife, Linda, which will be performed by the Pittsburgh Symphony Orchestra, Friday, September 7, 2012, 8 p.m., at Heinz Hall, 600 Penn Ave., Pittsburgh, to benefit pediatric cardiac research. "We are so honored Pittsburgh and its magnificent symphony will host and...

2012-07-11 02:26:03

ATLANTA, July 11, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2012 second quarter financial results will be released on Tuesday, July, 31, 2012. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive...

2012-07-03 06:25:16

New Program Provides Specialized Care for Patients and Helps Families Cope CHICAGO, July 3, 2012 /PRNewswire-USNewswire/ -- Bicuspid aortic valve (BAV) disease is the most common congenital heart defect, occurring in approximately one to two percent of the population. The condition is present when the aortic valve, the valve that connects the heart to the main artery that distributes blood to the body, contains two leaflets instead of three, which open and close to regulate blood...

2012-06-27 14:22:59

Scientists now have clues to how a gene mutation discovered in families affected with congenital heart disease leads to underdevelopment of the walls that separate the heart into four chambers. A Nationwide Children's Hospital study appearing in PLoS Genetics suggests that abnormal development of heart cells during embryogenesis may be to blame. When babies are born with a hole in their heart (either between the upper or lower chambers), they have a septal defect, the most common form of...

2012-06-14 10:23:17

ATLANTA, June 14, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device company focused on cardiac and vascular surgery, announced today that it has entered into a settlement agreement with CardioFocus, Inc. ending the outstanding patent dispute between CryoLife's wholly owned subsidiary, Cardiogenesis Corporation (acquired by CryoLife in May 2011), and CardioFocus that was pending in the United States District Court of Massachusetts. Under the terms of the settlement,...

2012-06-14 10:23:15

ATLANTA, June 14, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device company focused on cardiac and vascular surgery, announced today that it has reached full settlement of the outstanding CryoLife, Inc. v. Medafor, Inc. lawsuit that was pending in the Northern District Court of Georgia. Under terms of the settlement, Medafor has agreed to pay CryoLife $3.5 million in cash. Fifty percent of the payment is to be paid on or before July 9, 2012 and the...

2012-06-13 06:24:53

WEST BRIDGEWATER, Mass., June 13, 2012 /PRNewswire/ -- Cardiosolutions Inc., an emerging leader in structural heart solutions for valvular heart disease, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity(TM) Steerable Introducer, a next generation structural heart access introducer and delivery conduit. The Dexterity(TM) Steerable Introducer is designed to provide physicians straightforward and...

2012-06-01 23:03:46

World-renowned Professionals Connect with Families July 6 — 10th in Orlando to Discuss Cutting-edge Trends & Treatments Matawan, NJ (PRWEB) June 01, 2012 The International 22q11.2 Foundation Inc., an organization dedicated to improving the quality of life for people affected by chromosome 22q11.2 abnormalities through family and professional partnerships, is acting as the lead sponsor for The 8th Biennial International 22q11.2DS Conference in Orlando, FL,USA from July 6 -10th....


Latest congenital heart disease Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »